These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30064835)

  • 1. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
    J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model.
    Liu K; Cao G; Zhang X; Liu R; Zou W; Wu S
    Int J Nanomedicine; 2010 Oct; 5():853-60. PubMed ID: 21042547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model.
    Makino Y; Miyahara T; Nitta J; Miyahara K; Seo A; Kimura M; Suhara M; Akai A; Akagi D; Yamamoto K; Hoshina K
    J Surg Res; 2019 Jan; 233():104-110. PubMed ID: 30502235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
    Baek I; Bai CZ; Hwang J; Nam HY; Park JS; Kim DJ
    J Vasc Surg; 2012 Mar; 55(3):806-814.e1. PubMed ID: 22226184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel coating on the terminal portion of hemodialysis grafts effectively suppresses neointimal hyperplasia in a porcine model.
    Baek I; Hwang J; Park J; Kim H; Park JS; Kim DJ
    J Vasc Surg; 2015 Jun; 61(6):1575-82.e1. PubMed ID: 24581482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
    Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
    Kim AS; Werlin EC; Kagaya H; Chen M; Wu B; Mottola G; Jan M; Conte MS
    PLoS One; 2022; 17(2):e0264217. PubMed ID: 35226675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    J Cardiothorac Surg; 2011 May; 6():69. PubMed ID: 21569412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
    Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
    J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.
    Dai L; Gao M; Gu C; Zhang F; Yu Y
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):675-81. PubMed ID: 25838460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local application of paeonol prevents early restenosis: a study with a rabbit vein graft model.
    Zhang JY; Lei L; Shang J; Huo TM; Zhang B; Chen G; Zeng ZY; Li SK
    J Surg Res; 2017 May; 212():278-287. PubMed ID: 28550918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
    Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
    J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
    J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration.
    O'Blenes SB; Zaidi SH; Cheah AY; McIntyre B; Kaneda Y; Rabinovitch M
    Circulation; 2000 Nov; 102(19 Suppl 3):III289-95. PubMed ID: 11082403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid--U74389G.
    Davies MG; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Surg; 1994 Jul; 8(4):448-56. PubMed ID: 8088396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.